Number of the records: 1  

Polymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue

  1. 1.
    SYSNO ASEP0481666
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitlePolymer nitric oxide donors potentiate the treatment of experimental solid tumours by increasing drug accumulation in the tumour tissue
    Author(s) Studenovský, Martin (UMCH-V) RID, ORCID
    Sivák, Ladislav (MBU-M) RID
    Sedláček, Ondřej (UMCH-V) RID, ORCID
    Konefal, Rafal (UMCH-V) RID, ORCID
    Horková, Veronika (MBU-M)
    Etrych, Tomáš (UMCH-V) RID, ORCID
    Kovář, Marek (MBU-M) RID, ORCID
    Říhová, Blanka (MBU-M) RID
    Šírová, Milada (MBU-M) RID, ORCID
    Source TitleJournal of Controlled Release. - : Elsevier - ISSN 0168-3659
    Roč. 269, 10 January (2018), s. 214-224
    Number of pages11 s.
    Languageeng - English
    CountryNL - Netherlands
    Keywordsenhanced permeability and retention effect ; nitric oxide donor ; polymer-based cytotoxic drugs
    Subject RIVCD - Macromolecular Chemistry
    OECD categoryPolymer science
    Subject RIV - cooperationInstitute of Microbiology - Microbiology, Virology
    R&D ProjectsGA14-12742S GA ČR - Czech Science Foundation (CSF)
    NV16-28600A GA MZd - Ministry of Health (MZ)
    LQ1604 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    ED1.1.00/02.0109 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    Institutional supportUMCH-V - RVO:61389013 ; MBU-M - RVO:61388971
    UT WOS000423760400019
    EID SCOPUS85034437726
    DOI10.1016/j.jconrel.2017.11.017
    AnnotationThe delivery of nitric oxide (NO) specifically to solid tumours was explored in this study as a strategy to augment the passive accumulation of nanomedicines in tumours induced by the Enhanced Permeability and Retention (EPR) effect. An increase in accumulation was achieved by the binding of the chemical precursor of NO, based on an organic nitrate, to a water-soluble synthetic polymer drug carrier. Four structurally different N-(2-hydroxypropyl)methacrylamide (HPMA)-based polymer NO donors were synthesized. Depending on their chemical structure, two of these donors were hydrolytically stable, while two rapidly released the parent nitrate under acidic conditions, mimicking the intracellular environment. The polymer NO donors were shown to overcome the drawbacks related to low-molecular-weight NO releasing compounds, namely systemic toxicity, lack of site specificity, and fast blood clearance. The NO donors showed intracellular NO release upon incubation with tumour cells. In vivo, they potentiated the EPR effect, resulting in an increased accumulation of polymer-bound cytotoxic drug doxorubicin (Dox) in EL4 T-cell lymphoma inoculated in mice. This led to a better therapeutic outcome in the treatment of lymphoma with the high-molecular-weight polymer conjugates carrying Dox but not in the treatment with the free Dox. The localized augmentation of the EPR effect via the tumour-specific NO delivery system can be viewed as a promising strategy to potentiate polymer-based tumour therapy without increasing systemic toxicity.
    WorkplaceInstitute of Macromolecular Chemistry
    ContactEva Čechová, cechova@imc.cas.cz ; Tel.: 296 809 358
    Year of Publishing2019
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.